- VEON’s digital financial arms JazzCash and Mobilink Bank have already opened access to Pakistan Government 3‑month Treasury Bills via the JazzCash app, allowing eligible users to start investing from PKR 5,000 (about US$18) through a regulated, in‑app process.
- This move shifts government securities beyond traditional banks and brokers, potentially turning JazzCash’s 60 million‑strong base into one of the world’s largest retail digital investment channels in an emerging market.
- We’ll now explore how opening retail access to Pakistan Treasury Bills through JazzCash fits into, and may influence, VEON’s broader investment narrative.
Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.
VEON Investment Narrative Recap
To own VEON, you need to believe its shift from a traditional telecom to a digital and fintech platform in emerging markets can support resilient earnings despite macro and FX volatility. The JazzCash Treasury Bill launch directly supports the digital-finance catalyst by deepening engagement and fee potential, but it does not change the biggest near term risk, which remains exposure to unstable currencies and economies in Pakistan and other core markets.
Among recent announcements, the appointment of Serkan Ozturk as Chief of Staff & Strategy Officer looks most relevant here, because disciplined execution will matter if VEON wants to scale products like JazzCash T‑Bills across millions of users while managing costs. His remit to coordinate group priorities sits alongside these new fintech launches as VEON balances growth in lower margin digital services with the need to protect group profitability.
Yet beneath the fintech upside, VEON’s heavy exposure to volatile markets and currencies is something investors should be aware of...
Read the full narrative on VEON (it's free!)
VEON's narrative projects $5.7 billion revenue and $645.7 million earnings by 2029. This requires 7.6% yearly revenue growth and an earnings increase of about $113.7 million from $532.0 million.
Uncover how VEON's forecasts yield a $83.44 fair value, a 60% upside to its current price.
Exploring Other Perspectives
Some of the most cautious analysts see things very differently, expecting revenue of about US$5.6 billion and earnings near US$567.6 million by 2029, and worry that rising competition in digital finance could still limit how much initiatives like JazzCash T Bills really move the needle, which is a useful reminder that your view might differ as you compare these more pessimistic expectations with the upside you see in the latest news.
Explore 5 other fair value estimates on VEON - why the stock might be a potential multi-bagger!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your VEON research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
- Our free VEON research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate VEON's overall financial health at a glance.
No Opportunity In VEON?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
- Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 14 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com